Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Biotie Therapies: BTT1023 receives Orphan Drug Designation in US

Monday, August 29, 2016

FDA has granted Orphan Drug Designation for Bioties BTT drug candidate for treatment of primary sclerosing cholangitis PSC BTT is currently being studied for PSC in Phase a study BUTEO study Says twostage study design for BUTEO includes a preplanned...

Aurobindo, Intas in race for $1 billion buyout of Teva UK, submit binding offers

Monday, August 29, 2016

Home grown drug makers AurobindoBSE and Intas are among the final contenders for the UK and Irish portfolio of Israeli generics behemoth Teva put up for sale to comply with European antitrust regulations Both players have submitted binding offers...

Britain's FTSE edges lower as pharmaceuticals weigh again

Saturday, August 27, 2016

Britains top share index edged lower on Friday set to finish the week with falls as recent weakness in the pharmaceuticals continued with investors wary over political risk in the sector By GMT the FTSE was down points or percent at down perce...

FDA warns former Sun Pharma U.S. drug factory over quality concerns

Saturday, August 27, 2016

The US Food and Drug Administration has pulled up a former Sun Pharmaceutical drug factory for knowingly releasing lots of the hypertension drug clonidine last year despite proof that the raw materials used may have been contaminated This is one of...

Mylan offers discounts on EpiPen amid wave of criticism

Friday, August 26, 2016

Mylan NV said on Thursday it would reduce the outofpocket costs of its emergency EpiPen allergy injection for some patients amid a wave of criticism from lawmakers and the public over the products rapidly escalating price The list price of the drug...

Mallinckrodt Receives FDA Fast-Track Designation for Synacthen® Depot IND Application

Friday, August 26, 2016

Mallinckrodt plc a leading global specialty pharmaceutical company today announced the US Food and Drug Administration FDA has granted the companys request for a Fast Track designation for its Investigational New Drug IND application for Synacthen De...

Novartis announces positive phase III results for MS drug siponimod

Friday, August 26, 2016

Novartis AG said a latestage study showed its oral oncedaily BAF or siponimod reduced the risk of disability progression in a severe form of multiple sclerosis The Phase III EXPAND study the largest randomized controlled study in secondary progressi...

BioLineRx and I-Bridge Capital Establish a New Drug Development Joint Venture in China

Friday, August 26, 2016

BioLineRx Ltd a clinical stage biopharmaceutical company dedicated to identifying inlicensing and developing promising therapeutic candidates announced today that it has established a joint venture JV with IBridge Capital a Chinese venture capital fu...

Nymox Pharmaceutical announces new long-term fexapotide placebo crossover study results

Thursday, August 25, 2016

Nymox reports successful new longterm fexapotide placebo crossover study results major reduction in incidence of surgery Results show there was pct reduction in number of these patients who required surgery after they received crossover fexapotide...

Mylan Faces Scrutiny Over EpiPen Price Increases

Thursday, August 25, 2016

Mylan NV became the latest pharmaceutical company to face popular outrage about higher drug costs as attacks mounted Wednesday on the companys substantial price increases for the EpiPen emergency allergy treatment EpiPen is a lifesaving treatment fo...